Published in Br Med J (Clin Res Ed) on June 19, 1982
Immunization in Canada: current controversies. Can Fam Physician (1985) 0.75
Pertussis immunisation and serious acute neurological illness in children. Br Med J (Clin Res Ed) (1981) 8.48
Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58
Prevalent serotypes of Bordetella pertussis in non-vaccinated communities. J Hyg (Lond) (1976) 1.57
Biologically active components and properties of Bordetella pertussis. Adv Appl Microbiol (1976) 1.29
Whooping-cough in Hertfordshire. Lancet (1979) 1.27
Pertussis vaccine research. Bull World Health Organ (1981) 0.99
Pertussis agglutinins in vaccinated children: better response with adjuvant. J Hyg (Lond) (1974) 0.98
Histamine-sensitising factor of Bordetella pertussis differentiated from immunogens by neutralisation and passive protection tests. J Pathol Bacteriol (1967) 0.90
The potency of whooping cough (pertussis) vaccines in Canada. J Biol Stand (1980) 0.90
Reducing the endotoxic activity of pertussis vaccine. J Hyg (Lond) (1981) 0.85
Pertussis vaccine. Br Med J (Clin Res Ed) (1981) 0.82
Death of infants after triple vaccine. Lancet (1979) 0.82
Technical problems in the laboratory diagnosis and prevention of whooping-cough. Lab Pract (1970) 3.05
Potency tests for pertussis vaccines: doubtful value of intracerebral challenge test in mice. J Pathol Bacteriol (1966) 2.73
Toxoid vaccine for pertussis. Lancet (1997) 2.43
Efficacy of pertussis vaccines: a brighter horizon. Br Med J (1972) 2.04
Protection by pertussis vaccine. Little cause for concern. Lancet (1976) 1.63
Change in serotype of pertussis infection in Britain. Lancet (1985) 1.60
Prevalent serotypes of Bordetella pertussis in non-vaccinated communities. J Hyg (Lond) (1976) 1.57
Agglutinin response to pertussis vaccination in the child. Br Med J (1971) 1.51
Variation of serotype in strains of Bordetella pertussis. J Hyg (Lond) (1974) 1.50
Measles control in young infants. Lancet (1993) 1.45
Polio eradication. Lancet (1994) 1.40
Experimental pertussis infection in the marmoset: type specificity of active immunity. J Hyg (Lond) (1974) 1.31
Identification of Vibrio cholerae by pyrolysis gas-liquid chromatography. Appl Microbiol (1973) 1.30
Mouse or man? Which are pertussis vaccines to protect? J Hyg (Lond) (1976) 1.28
Whooping-cough in Hertfordshire. Lancet (1979) 1.27
Letter: Whooping-cough vaccination. Lancet (1974) 1.19
Some unsolved problems with vaccines. Prog Drug Res (1979) 1.12
A reappraisal of serotype factors 4, 5 and 6 of Bordetella pertussis. J Hyg (Lond) (1982) 1.11
Cholera vaccines: lessons from Rwanda and elsewhere. Lancet (1997) 1.10
Whooping cough in northern Israel. Isr J Med Sci (1972) 1.08
Essential immunogens in human pertussis: the role of fimbriae. Dev Biol Stand (1985) 1.02
Experimental pertussis infection in the rabbit: similarities with infection in primates. J Infect (1980) 1.01
Some factors affecting the haemolytic activity of Vibrio cholerae. J Med Microbiol (1974) 0.99
Pertussis agglutinins in vaccinated children: better response with adjuvant. J Hyg (Lond) (1974) 0.98
Recognising whooping cough. Br Med J (Clin Res Ed) (1986) 0.98
Accelerated immunisation with diphtheria-tetanus-pertussis vaccine. BMJ (1991) 0.98
Machakos project studies. Agents affecting health of mother and child in a rural area of Kenya. V. Pertussis sentypes in Kenyan children 1974--1975. Trop Geogr Med (1978) 0.95
Application of pulsed field gel electrophoresis to the 1993 epidemic of whooping cough in the UK. Epidemiol Infect (1995) 0.94
Pertussis agglutinins in vaccinated mice : difficulty in estimating the type-specific response. Indian J Med Res (1976) 0.91
Histamine-sensitising factor of Bordetella pertussis differentiated from immunogens by neutralisation and passive protection tests. J Pathol Bacteriol (1967) 0.90
Whooping cough in West Germany. Lancet (1985) 0.88
Efficacy of whooping-cough vaccines. Br Med J (1973) 0.82
What makes a good pertussis vaccine? Prog Drug Res (1975) 0.82
Vaccine composition in relation to antigenic variation of the microbe: is pertussis unique? Prog Drug Res (1975) 0.80
Characterization of outbreak and vaccine strains of Bordetella pertussis--Quebec. Can Commun Dis Rep (1993) 0.80
Current pharmacotherapy of pertussis. Expert Opin Pharmacother (2001) 0.79
Pertussis component vaccine in Japan. Lancet (1984) 0.78
Type-specific action of vibriocidal antibody on Vibrio cholerae. J Hyg (Lond) (1975) 0.78
Association between Bordetella pertussis agglutinogen 2 and fimbriae. J Med Microbiol (1984) 0.77
Pulmonary pertussis infection in the mouse: no solution to an old problem. J Infect (1981) 0.76
Transmission of pertussis: do adults have an important role? Lancet (1996) 0.76
Assessing the response to pertussis vaccine. BMJ (1991) 0.75
Components of acellular pertussis vaccines. Lancet (1996) 0.75
Immunisation of the preterm baby. J Infect (1994) 0.75
Publication bias via suppressed expert conflict. Lancet (1993) 0.75
Immunological and bacteriological distinction between parapertussis and pertussis. Lancet (1995) 0.75
Diphtheria, pertussis, and tetanus vaccination. Lancet (1992) 0.75
Acellular pertussis vaccines: progress but déjà vu. Lancet (1998) 0.75
Cholera treatment. Lancet (1994) 0.75
Cholera isolates in relation to the "eighth pandemic". Lancet (1993) 0.75
Letter: Immunisation against whooping cough. Br Med J (1976) 0.75
Measles and pertussis: the timing of vaccination. Lancet (1995) 0.75
Changing advice on vaccination. Br Med J (1979) 0.75
Whooping-cough immunization: fact and fiction. Public Health (1980) 0.75
Typhoid vaccine and laboratory indicators of clinical protection. Lancet (1992) 0.75
Influence of challenge strain on potency of pertussis vaccines in mice. Nature (1967) 0.75
Campylobacter serotypes and epidemiology. Lancet (1981) 0.75
Whooping-cough vaccination. Br Med J (1979) 0.75
Antigens that modern vaccines must contain. Lancet (1990) 0.75
The motility of some clostridium species. J Gen Microbiol (1969) 0.75
Vaccination and the eradication of infectious diseases. Natl Med J India (1998) 0.75
Maternal antibody against pertussis. Br Med J (1977) 0.75
Pertussis vaccine efficacy in Birmingham. Commun Dis Public Health (2000) 0.75
Experimental pertussis infection in the vaccinated and unvaccinated marmoset: similarities to natural infection in the child. J Clin Pathol (1972) 0.75
Whooping cough vaccine efficacy. Lancet (1982) 0.75
Whooping cough in Stuttgart. Lancet (1988) 0.75
Eradication of pertussis by vaccination. Lancet (1987) 0.75
Pertussis antibodies in vaccinated children. Lancet (1983) 0.75
Whooping-cough vaccine. Lancet (1977) 0.75
Centenary of the Gram-stain. J Infect (1984) 0.75
Vibrio cholerae in South America. Lancet (1984) 0.75
Promiscuity and the abuse of stigma. Lancet (2000) 0.75